We use proven technology with a high level of reliability. Our MASTR technology is unique because we are able to perform very complex genetic analyses easily, correctly and quickly.
Recent advances in various areas of clinical medicine, diagnostics and genetic testing have created a significant opportunity for the development of high value genetic tests to enable the practice of personalized medicine.
The availability of affordable Massively Parallel Sequencing systems provides the foundation on which PCR based technologies can be applied to address a wide range of unmet needs.
Multiplex PCR is a molecular biology technique for the amplification of multiple genomic targets in a single PCR experiment.
Multiplicom applies highly multiplexed PCR to develop assays that greatly enhance the overall efficiency and application of genetic testing that can be operated on standard instrumentation.
Multiplicom’s Multiplex PCR technology results in highly efficient, low-cost assays enabling a wide range of clinical and diagnostic applications.
Every assay benefits fully from the main advantages of multiplex-based PCR, compared to enrichment methods: